Driving the Day

Today is May 8, 2025, and here are the key policymaker and stakeholder actions on AI you need to know: In Washington, the Trump Administration announced it will rescind the Biden Administration’s AI diffusion rule. Meanwhile, the Food and Drug Administration is meeting with OpenAI to discuss the use of OpenAI’s technology in drug evaluations. Across the pond, the EU’s trade commissioner promised the EU would increase economic cooperation with the U.S. on AI. Lastly, Semafor discussed how “not-in-my-backyard” activism is putting pressure on the tech industry’s AI infrastructure buildout.

In this issue:

• Washington in Focus: OpenAI, Microsoft, and AMD executives testified on Capitol Hill.

• Around the Nation: California’s privacy agency retreated from proposed rules that would have regulated how AI can be used in advertising and tracking consumers.

• Across the Pond: The Telegraph discussed the Labour government’s reversal on AI copyright issues.

• Global Highlights: AI researchers from the US, Europe, and Asia came together in Singapore to form a plan for assessing AI risks.

• Outside Views: The Federalist Society discussed the state of play for AI defamation cases.

Read these stories and more below: